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RESEARCH ARTICLE
Giantin-knockout models reveal a feedback loop between
Golgi function and glycosyltransferase expression
Nicola L. Stevenson1, Dylan J. M. Bergen1,2, Roderick E. H. Skinner2, Erika Kague2,
Elizabeth Martin-Silverstone2, Kate A. Robson Brown3, Chrissy L. Hammond2 and David J. Stephens1,*
ABSTRACT
The Golgi is the cellular hub for complex glycosylation, controlling
accurate processing of complex proteoglycans, receptors, ligands
and glycolipids. Its structure and organisation are dependent on
golgins, which tether cisternal membranes and incoming transport
vesicles. Here, we show that knockout of the largest golgin, giantin,
leads to substantial changes in gene expression but only limited effects
onGolgi structure. Notably, 22Golgi-resident glycosyltransferases, but
not glycan-processing enzymes or the ER glycosylation machinery,
are differentially expressed following giantin ablation. This includes
near-complete loss of function of GALNT3 in both mammalian cell and
zebrafish models. Giantin-knockout zebrafish exhibit hyperostosis
and ectopic calcium deposits, recapitulating phenotypes of
hyperphosphatemic familial tumoral calcinosis, a disease caused by
mutations in GALNT3. These data reveal a new feature of Golgi
homeostasis: the ability to regulate glycosyltransferase expression to
generate a functional proteoglycome.
KEY WORDS: Golgi, Giantin, Glycosylation, GALNT3,
Hyperphosphatemic tumoral calcinosis, Zebrafish
INTRODUCTION
Golgins are coiled-coil domain proteins that project out from the
surface of the Golgi into the cytosol (Gillingham andMunro, 2016).
They maintain Golgi organisation and selectively tether incoming
transport vesicles seeking to fuse with Golgi cisternae. The largest
golgin family member is giantin (also known as GOLGB1), whose
N-terminal cytosolic domain has a predicted molecular mass of
370 kDa (Linstedt and Hauri, 1993). Giantin is one of only three
golgins to have a C-terminal transmembrane domain, directly
anchoring it within cis- and medial-Golgi membranes.
The functional role of giantin is poorly defined. Early in vitro
studies suggest that giantin resides in COPI vesicles, which are
transport carriers mediating intra-Golgi and retrograde Golgi-to-
endoplasmic reticulum (ER) transport (Sönnichsen et al., 1998).
Here, giantin is reported to recruit the general vesicular transport
factor p115 (also known as USO1), which binds simultaneously to
GM130 (GOLGA2) on cis-Golgi membranes to mediate tethering.
Giantin–p115 interactions may also facilitate GM130-independent
retrograde transport (Alvarez et al., 2001). In addition to p115,
giantin has been shown to interact with GCP60 (Sohda et al., 2001),
Rab1 and Rab6 (Rosing et al., 2007). Rab1 and Rab6 localise to ER-
Golgi and retrograde transport vesicles, respectively, and thus their
interaction with Golgi-resident giantin could similarly promote
vesicle capture. Furthermore, giantin is also implicated in lateral
Golgi tethering (Koreishi et al., 2013) and ciliogenesis (Asante
et al., 2013; Bergen et al., 2017).
Rodent models carrying loss-of-function alleles of giantin vary in
phenotype. Homozygous knockout (KO) rats, possessing a null
mutation in the Golgb1 gene, which encodes giantin, develop late
embryonic lethal osteochondrodysplasia (Katayama et al., 2011).
Embryonic phenotypes include systemic oedema, cleft palate,
craniofacial defects and shortened long bones which are largely
attributed to defects in chondrogenesis. Interestingly, chondrocytes
from homozygous animals have expanded ER and Golgi membranes
whilst cartilage growth plates contain less extracellular matrix
(ECM), indicative of secretory pathway defects (Katayama et al.,
2011). Mouse giantin-KO models have less-complex developmental
disorders, with the predominant phenotype being cleft palate (Lan
et al., 2016) and short stature (McGee et al., 2017). These animals
also have ECM abnormalities associated with glycosylation defects,
but Golgi structure is normal (Lan et al., 2016). Work from our lab
has also now characterised giantin function in zebrafish (Bergen et al.,
2017). In contrast to rodent models, homozygous giantin-KO
zebrafish do not show any gross morphological changes during
development, can reach adulthood and show only a minor growth
delay. They do, however, show defects in cilia length consistent with
our previous work in vitro (Asante et al., 2013). We have also
defined defects in procollagen secretion following RNAi of giantin
expression in cultured cells (McCaughey et al., 2016). Thus, defects
in ECM assembly could underpin some of the developmental
defects seen in giantin-KO model organisms.
There are two major pathways of protein glycosylation, N- and O-
glycosylation, initiated in the ER and Golgi, respectively. Most
oligosaccharides are then subject to modification and extension by
Golgi-resident type II transmembrane glycosyltransferases, the
importance of which is underscored by the clear link between Golgi
dysfunction and congenital disorders of glycosylation (Freeze and
Ng, 2011). Mucin-type O-glycosylation is the most prevalent form
of glycosylation on cell surface and secreted proteins. It is initiated
by Golgi-resident polypeptide N-acetylgalactosaminyltransferases
(GALNTs) that catalyse the addition of N-acetylgalactosamine to
serine or threonine residues on target substrates (forming the Tn
antigen; Bennett et al., 2012). There are 20 GALNT proteins in
humans with distinct but overlapping substrate specificities andReceived 19 October 2017; Accepted 21 October 2017
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spatio-temporal expression patterns (Bard and Chia, 2016;
Schjoldager et al., 2015). Such redundancy means mutations in
GALNT genes generally produce very mild phenotypes, although
several genome-wide association studies have linked GALNTs with
diverse pathologies such as Alzheimer’s disease (Beecham et al.,
2014) and obesity (Ng et al., 2012). Moreover, bi-allelic loss-of-
function mutations in GALNT3 have been directly linked to the
human disease hyperphosphatemic familial tumoral calcinosis
(HFTC; Ichikawa et al., 2007; Kato et al., 2006; Topaz et al.,
2004). In such cases, complete loss of GALNT3 function results in a
failure to O-glycosylate FGF23, leading to its inactivation and the
subsequent development of hyperostosis and ectopic calcium
deposits in skin and subcutaneous tissues.
In the absence of a clearly defined role for giantin at the Golgi, we
sought to study its function in an engineered KO cell line. In this
system, as well as a zebrafish model, we show for the first time that
loss of giantin results in changes in the expression of Golgi-resident
glycosyltransferases, defining a new role for giantin in quality
control of Golgi function through transcriptional control.
RESULTS
Generation of a giantin-KO cell line
We generated a KO cell line for GOLGB1 using genome editing. A
GFP fusion of the double nickase mutant of Cas9 (Cas9D10A-GFP)
was co-transfected into human non-transformed telomerase
immortalized retinal pigment epithelial (hTERT-RPE-1) cells
with paired guide RNAs targeting exon 7 of GOLGB1. GFP-
positive cells were then sorted by fluorescence-activated cell
sorting, screened for loss of giantin by immunofluorescence, and
sequenced at the target site. Using this approach, one clone was
identified with an indel frameshift mutation in both alleles, leading
to a frameshift and premature stop codon in exon 4 (full annotation:
R195fsX204-R195P-A196del, Fig. 1A). Downstream of the
mutation, an in-frame translational start site was also noted with
the potential to permit expression of a truncated protein. To exclude
this possibility, we probed the mutant cells for giantin expression
using three different antibodies raised against the full-length
protein, and C- and N-termini of the protein. No protein was
detected by immunoblot or immunofluorescence using these
antibodies (Fig. 1B–D).
Loss of giantin does not lead to gross defects in Golgi
morphology or trafficking
As giantin resides at the Golgi, we began characterising the KO cell
line by examining Golgi morphology. KO cells were
immunolabelled for Golgi markers and the size and number of
Golgi elements were quantified. No significant change in Golgi
structure was detected (Fig. 2A–C). The relative distribution of cis-
Fig. 1. Generation of a giantin-KO cell line. (A) Genomic sequence for CRISPR/Cas9 target site in WT and engineered KO RPE-1 cell line. Purple lines and
scissors depict gRNA binding and cut sites. Blue nucleotides show the CRISPR PAM site. Green and red nucleotides are those deleted and inserted in the KO
mutation, respectively. Amino acid translation shown underneath; asterisk indicates a premature stop codon. (B,C) Western blot analysis (B) and
immunofluorescence staining (C) of giantin using three different antibodies raised against the C-terminus (C-term), N-terminus (N-term) and full-length (FL)
protein. All immunoreactivity is lost in the KO cells. (D) WT and KOmixed population stained for giantin and other Golgi markers for direct comparison. Images are
maximum projections. Scale bars: 10 µm.
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and trans-Golgi markers was also maintained, suggesting that
organelle polarity was unperturbed (Fig. 2D). Similarly, the general
organisation of the early secretory pathway was normal (Fig. 2E,
showing labelling for ER-exit sites and ER-Golgi intermediate
compartment). We therefore decided to study Golgi morphology in
greater detail by electronmicroscopy (EM). At this resolution, Golgi
stacks had comparable numbers of cisternae in wild-type (WT) and
KO cells, and cisternae were of equivalent length with no sign of
Fig. 2. See next page for legend.
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dilation (Fig. 2F–H). Overall, these results suggest that Golgi
structure was not grossly disrupted following loss of giantin.
Many golgins have been shown to act as tethers for transport
vesicles, but such a function has not yet been defined for giantin
(Wong and Munro, 2014). To test whether giantin is involved in
trafficking, we used the retention using selective hooks (RUSH)
system (Boncompain et al., 2012) tomonitor ER-to-Golgi transport. In
this assay, a fluorescently labelled Golgi-resident reporter protein
(here, EGFP-tagged mannosidase II) is fused to streptavidin binding
protein (SBP) and co-expressed with an ER-resident protein ‘hook’
fused to streptavidin (here tagged with a KDEL motif). When both
engineered fusion proteins are present, the SBPon the reporter binds to
the streptavidin on the hook and is retained in the ER. Reporter release
is then induced by the addition of biotin, which outcompetes the SBP
for streptavidin binding. Time-lapse imaging of biotin-treated KO
cells expressing this RUSH construct (Movies 1 and 2) showed a
slight delay and greater variability in anterograde mannosidase II
trafficking relative to that in the WT, however this difference was not
statistically significant (Fig. 2I,J). In order to analyse a greater number
of cells, we repeated this experiment in fixed cells at 0, 10 and 20 min
after addition of biotin and quantified cargo delivery at each time
point. Again, giantin-KO cells showed no significant delay in
anterograde transport compared with transport in WT cells (Fig. 2K,
L). This approach also allowed us to confirm that we were observing
ER-Golgi transport as we could co-label the Golgi (Fig. 2L).
Perturbations in anterograde trafficking can result in ER stress
and activation of the unfolded protein response (UPR) as secretory
cargo accumulates in this compartment (Brodsky, 2012). We found
that expression of UPR markers including PERK (EIF2AK3),
calnexin and CHOP (DDIT3) were unchanged in giantin-KO cells
compared with controls (Fig. 2M), suggesting that the UPR is not
activated in giantin-KO cells.
GM130 localisation is altered in giantin-KO cells following
Golgi fragmentation
During mitosis, the Golgi must disassemble and reassemble. As we
could not detect any gross defects in Golgi structure in giantin-KO
cells at steady state, we analysed Golgi dynamics by chemically
inducing its disassembly. First, we treated cells with nocodazole,
which disassembles microtubules and thus causes Golgi ribbons to
fragment into polarised mini-stacks (Thyberg and Moskalewski,
1985). Under these conditions, the dynamics of disassembly and
reassembly were found to be equivalent in both cell lines (Fig. 3A),
with fragmentation of the TGN preceding that of the cis-Golgi as
reported previously (Yang and Storrie, 1998). Likewise, Golgi
disassembly following treatment with Brefeldin A (which inhibits
the Arf-guanine nucleotide exchange factor, GBF1) was
comparable in WT and KO cells (Fig. S1). We also failed to find
any defects in cell cycle progression using propidium iodide
labelling and flow cytometry (data not shown).
During these Golgi disruption experiments, we noticed a
difference in GM130 labelling of WT and KO cells. Following
nocodazole treatment, giantin reportedly persists on the original
fragmentingmembranes (the ‘oldGolgi’) rather than cycling through
the ER onto immature peripheral mini-stacks (Fourriere et al., 2016;
Nizak et al., 2003). This is apparent here inWT cells, which show an
enrichment of giantin on larger, juxtanuclear structures over more
peripheral elements (Fig. 3A). In KO cells however, these larger
Golgi elements are enrichedwithGM130. This enrichment is not due
to upregulation ofGM130 expression, as protein levels are equivalent
in WT and KO cells (Fig. 3B,C) suggesting instead that GM130 has
either redistributed between Golgi membranes, perhaps to
compensate for giantin, or is labelling larger structures that are not
present in WT cells. To distinguish between these possibilities, we
examined cells treated with nocodazole for 90 min by EM. As
expected larger, perinuclear ‘old Golgi’ structures could be detected
in bothWT andKO cells, as well as peripheral mini-stacks (Fig. 3D).
The size distribution of these structures was equivalent in both cell
lines (Fig. 3E,F), indicating that the larger GM130-labelled elements
reflect a redistribution of the protein.
Giantin-negative Golgi ‘mini-stacks’ show a tendency to
circularise
Surprisingly, EM analysis of nocodazole-treated KO cells showed
Golgi elements that had apparently circularised (Fig. 3D, insets).
These were absent in WT and untreated KO cells, except for one
case of the latter. To quantify the curvature of fragmented Golgi
elements we calculated the angle between two lines drawn from
each Golgi rim to the centre of the stack; circularised Golgi
structures were assigned an angle of 0° and linear stacks 180°. This
analysis showed a significant overall trend towards horseshoe-
shaped and circular stacks in the KO cells compared with the WT
(Fig. 3G). Giantin-deficient Golgi stacks therefore exhibit structural
abnormalities with low frequency (5% of structures, with at least
one present in 14% of cells) once fragmented.
Glycosylation enzyme expression patterns are altered in
giantin-KO cells
Giantin is an evolutionarily conserved gene that is essential for
viability in rodents (Katayama et al., 2011; Lan et al., 2016), yet
phenotypes in our KO cell line and indeed in KO zebrafish (Bergen
et al., 2017) are mild. We therefore considered whether the cells had
undergone adaptation, as reported for other KO systems (Rossi et al.,
2015). Having established that the expression of other golgin family
members was normal (Fig. 3B,C), we performed RNA-seq of WT
and KO cells to compare gene expression patterns in an unbiased
manner. Pair-wise analysis of triplicate samples identified a total of
1519 genes showing a greater than 2-fold change in expression in
KO cells. Of those, 807 genes exhibited a greater than 3-fold change
Fig. 2. Loss of giantin has no effect on Golgi structure or trafficking.
(A) Representative images of WT and KO cells immunolabelled for two cis-
Golgi markers. (B,C) The number of GM130-positive elements per cell (B) and
their area (C) was found to be equivalent in WT and KO cells (n=3; 387WTand
320 KO cells quantified; orange bars indicate median and interquartile range;
statistics Mann–Whitney; fragments smaller than 0.5 μm2 excluded). (D) Co-
labelling of cells with cis-Golgi (GM130) and trans-Golgi (TGN46) markers
shows Golgi polarity is maintained in KO cells. (E) Representative images of
WT and KO cells immunolabelled for early secretory pathway markers as
indicated. In A,D,E, images are maximum projections. Scale bars: 10 μm.
(F–H) Transmission electron micrographs of Golgi elements in WT and KO
cells. The number of cisternae per stack (G) and length of Golgi cisternae (H)
was quantified from experiments represented in F (n=3; total 30 cells per cell
line; orange bars indicate median and interquartile range; statistics Mann–
Whitney). (I–L) WT and KO cells expressing Str-Kdel/ManII-SBP-EGFP were
treated with biotin and imaged live (I,J) or fixed at 0, 10, and 20 min post-biotin
addition and immunolabelled for GM130 (K,L). (I) Single-plane images taken
from representative movies at 5 min intervals. See Movies 1–6. Scale bar:
10 μm. Arrows show arrival of reporter at Golgi. (J) Quantification of the time at
which fluorescence appears in the Golgi in movies represented in I (n=3; 15
WT cells and 23 KO cells quantified; bars showmedian and interquartile range;
statistics Mann–Whitney). (K) Quantification of the number of GFP-positive
Golgi at each time point in fixed cells (n=3; 378WTand 310KO cells quantified;
mean and s.d. shown). (L) Representative single-plane images of fixed cells at
each time point. Scale bars: 10 μm. (M) Western blot analyses of ER stress
markers in lysates taken from WT and KO cells following treatment with
Brefeldin A for the indicated time.
4135
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 4132-4143 doi:10.1242/jcs.212308
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Fig. 3. Loss of giantin leads to mild changes in Golgi mini-stack structure. (A) Representative maximum projection images of WT and giantin-KO cells
incubated with 5 µm nocodazole as indicated and immunolabelled for cis-Golgi (GM130) and trans-Golgi (TGN46) markers or tubulin. In wash-out panels, cells
were incubated with nocodazole for 3 h then washed and incubated in growth medium for time indicated. Scale bars: 10 μm. (B) Western blot analysis of golgin
expression in WT and KO cells. (C) Quantification of blots represented in B (n=3, mean and s.d. shown). (D) Transmission electron micrographs of WT and KO
cells incubated with 5 μM nocodazole for 90 min. Inserts show zoom of region denoted by black squares. (E–G) Quantification of experiments represented in D
showing (E) cisternal length, (F) number of cisternae per stack and (G) the angle between lines drawn from each lateral rim of the stack to the centre (n=3; 27 WT
and 21 KO cells quantified; E and G show median and interquartile range; F, mean and s.d.; statistics Mann–Whitney).
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in expression in KO cells (Table S1). Gene ontology analysis
showed that the major classes of genes that were differentially
expressed encoded highly glycosylated proteins, extracellular
matrix components, and adhesion proteins. Twenty-four
glycosyltransferases were differentially expressed between the two
cell lines. These include a pseudogene (DPY19L2P2), an
ER-resident glycosyltransferase (UGT8) and 22 type II Golgi-
resident transmembrane enzymes (Table 1). Some of these were
among the most highly downregulated genes overall. Notably, other
ER-localised core glycosyltransferases, glycan processing and
modifying enzymes, and the cytosolic glycosylation machinery
were unchanged following KO of giantin.
To determine the impact of altered glycosyltransferase
expression in the KO cells, we looked at global glycosylation
patterns using biotinylated lectins to label fixed cells. RCA120
labelling of β-D-galactosyl residues was more bundled in KO cells,
but otherwise there were no gross changes in glycan abundance or
localisation (Fig. S2). We also probed cell lysates with lectins by
blotting and found only minor changes in glycosylation patterns,
namely loss of a 25 kDa band when labelling with either
hyaluronic acid binding protein (HABP) or Concanavalin A,
which recognises α-D-mannosyl and α-D-glucosyl residues
(Fig. S2). Glycosylation patterns are therefore largely normal,
but with some identifiable changes.
GALNT3 expression is substantially reduced in giantin-KO
cells
Tovalidate the findings of theRNA-seq analysis, we first performed an
immunoblot for one of the more highly downregulated
glycosyltransferases, GALNT3. This confirmed that protein
expression was almost completely abolished in five biological
replicates (Fig. 4A). Immunolabelling of fixed cells further
demonstrated a near-complete loss of GALNT3 expression in
giantin-KO cells (Fig. 4B). Additionally, investigation into RCAN2,
the most highly upregulated gene overall, similarly corroborated the
RNA-seq results at the protein level (Stevenson et al., 2017 preprint).
GALNT3 is mutated in the human disease HFTC (Topaz et al.,
2004) and so we decided to focus our studies on this gene. We
hypothesised that downregulation of GALNT3 could have occurred
in response to aberrant trafficking following the loss of giantin
function; such mistargeting could result in degradation coupled with
a feedback mechanism to downregulate expression. We tested this
directly by expressing FLAG-tagged GALNT3 inWT and KO cells.
Immunofluorescence labelling showed FLAG–GALNT3 is
efficiently targeted to the Golgi in both cell lines (Fig. 4C).
GALNT3 localisation is thus independent of giantin function and
not the cause of its down-regulation. We next decided to test
whether GALNT3 down-regulation was reversible by reintroducing
epitope-tagged giantin into KO cells. Giantin-KO cells expressing
FLAG–giantin for up to 2 weeks failed to show any recovery of
GALNT3 protein expression (data not shown).
Giantin-KO zebrafish phenotypes are consistent with
tumoral calcinosis
We next sought to explore the role of giantin in regulating
glycosyltransferase expression in vivo, using two recently
characterised golgb1-KO zebrafish lines (Bergen et al., 2017).
The first of these, derived by ENU mutagenesis, carries a point
mutation (C>T) in exon 14 leading to generation of a premature stop
codon at glutamine 2948 (denoted golgb1Q2948X/Q2948X). The
second allele was generated by TALEN site-directed mutagenesis,
introducing an 8 bp insertion at exon 14. This results in a frameshift
at position 3029, leading to a premature stop codon at position 3078
(E3027fsX3078-T3028_A3029del, denoted golgb1X3078/X3078).
Both mutations lead to loss of the transmembrane domain and
therefore are expected to be loss-of-function mutations. These fish
Table 1. Glycosylation enzymes differentially expressed between WT and giantin-KO RPE-1 cells
Gene WT FPKM KO FPKM log2 (fold change) P-value q-value Pathway Organelle
GALNT5 0.0293487 0.693322 4.56216 5.00E-05 0.000214 N-glycosylation Golgi
ST6GALNAC3 0.302522 2.43643 3.00966 5.00E-05 0.000214 O-glycosylation Golgi
EXTL1 0.417023 1.00605 1.2705 5.00E-05 0.000214 N-glycosylation Golgi
CSPG5 0.351491 0.173152 −1.02145 0.0001 0.000408 O-glycosylation Golgi
GAL3ST3 0.252928 0.123266 −1.03695 0.00015 0.000591 Both N- and O-glycosylation Golgi
GALNT1 153.498 71.0283 −1.11175 5.00E-05 0.000214 O-glycosylation Golgi
DPY19L2P2 1.60655 0.718415 −1.16107 5.00E-05 0.000214 C-glycosylation Pseudogene
ST6GALNAC2 0.595085 0.24238 −1.29582 5.00E-05 0.000214 N-glycosylation Golgi
MGAT5B 6.70667 2.5532 −1.39329 5.00E-05 0.000214 N-glycosylation Golgi
GALNT16 9.52671 3.35166 −1.5071 5.00E-05 0.000214 O-glycosylation Golgi
B4GALNT4 9.7297 3.34711 −1.53948 5.00E-05 0.000214 O-glycosylation Golgi
B3GNT5 1.77188 0.581017 −1.60863 5.00E-05 0.000214 O-glycosylation Golgi
A4GALT 6.16651 1.7832 −1.78999 5.00E-05 0.000214 O-glycosylation Golgi
HS3ST1 1.92483 0.54196 −1.82847 5.00E-05 0.000214 O-glycosylation Golgi
LFNG 2.58988 0.653085 −1.98754 5.00E-05 0.000214 Both N- and O-glycosylation Golgi
CHST11 9.46678 1.97911 −2.25802 5.00E-05 0.000214 O-glycosylation Golgi
CHSY3 0.8767 0.161329 −2.44208 5.00E-05 0.000214 O-glycosylation Golgi
GALNT12 1.42884 0.199249 −2.84221 5.00E-05 0.000214 O-glycosylation Golgi
GBGT1 2.71611 0.233266 −3.54149 5.00E-05 0.000214 Glycolipid glycosylation Golgi
FUT4 0.904089 0.0770361 −3.55286 5.00E-05 0.000214 N-glycosylation Golgi
UGT8 4.82991 0.272601 −4.14714 5.00E-05 0.000214 Glycolipid glycosylation ER
GALNT3 8.35694 0.33148 −4.65598 5.00E-05 0.000214 O-glycosylation Golgi
ST6GAL2 0.699234 0.0208263 −5.0693 5.00E-05 0.000214 N-glycosylation Golgi
ST8SIA4 0.341234 0 – 5.00E-05 0.000214 N-glycosylation Golgi
Values shown are fragments per kilobase of transcript per million mapped reads (FPKM), the log2-fold change between these and the uncorrected P- and q-
values [q being the false discovery rate (FDR)-adjusted P-value]. All values were found to be significant (where P>FDR after Benjamini–Hochberg correction for
multiple-testing). Pathway annotation and steady-state localisation was done manually based on gene ontology and published literature. Genes highlighted in
pink are downregulated and in green are upregulated
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do not display any gross developmental defects, but did have a mild
developmental delay and an increase in cilia length (Bergen et al.,
2017).
Given the skeletal defects seen in human patients lacking
GALNT3 function and in giantin-KO rodents, we performed
quantitative PCR of mixed bone and cartilage tissues from both
mutant fish lines at 60 days post fertilisation (dpf). In each case, we
observed a significant reduction of galnt3 expression (Fig. 5A) with
one KO individual from each line possessing almost undetectable
levels of transcript. Since the giantin-KO fish reach adulthood, and
given the causative link between loss of GALNT3 and HFTC in
humans, we next examined WT and mutant skeletal structures by
micro-computed tomography (micro-CT) in both mutant lines; three
mutants and siblings of the Q2948X line were scanned at 8 months
post fertilisation and four mutants and siblings of the X3078 line
were scanned at 10 months post fertilisation. Both mutant lines
showed relatively normal skeletal patterning consistent with the
published phenotype (Fig. 5B–I and Bergen et al., 2017). However,
both lines exhibited ectopic mineralisation of soft tissues. All four
mutants from the X3078 line showed ectopic mineralisation of the
intervertebral discs, leading to reduction in vertebral spacing and
vertebral fusions (Fig. 5B,C). Furthermore, two out of three
golgb1Q2948X/Q2948X adults showed ectopic calcium-like deposits
in the soft tissues of the thoracic cavity near bone elements (Fig. 5D,
G and Movies 3 and 4), while the third showed deposits within
multiple vertebrae (Fig. 5I, and Movies 5 and 6). In addition to
aberrant mineralisation, HFTC is also associated with hyperostosis.
Accordingly, as well as the fused vertebrae in both mutant lines, we
also observed craniofacial alterations such that the lower jaw was
longer and narrower than in their WT siblings (Fig. S3), consistent
with altered bone deposition (Fig. S3). Total bone mineral density
was not significantly different between the mutants and siblings.
However, when readings were taken across large volumes in the jaw,
skull or vertebrae, we observed higher variability in the mutants
than in the WT fish. This is also consistent with alterations to
skeletal homeostasis (Fig. S3).
DISCUSSION
The data presented here demonstrate for the first time that the Golgi
has the capacity to control its own enzymatic composition through
changes in transcription. Specifically, we show that the enzymatic
content of the Golgi is altered at the level of transcription in response
to loss of giantin function. The ER and cytosolic glycosylation
machineries, as well as Golgi-localised glycosidases, are
unaffected. This process is conserved between mammalian cells
and zebrafish models asGALNT3mRNA is reduced in both giantin-
KO systems. Furthermore, we demonstrate this has functional and
physiological relevance as giantin-KO zebrafish show ectopic
calcified structures, similar to phenotypes seen in the human
congenital disorder of glycosylation, HFTC.
We report that 24 enzymes involved in multiple glycosylation
pathways exhibit altered expression following GOLGB1 ablation.
This implies that this change does not occur in response to a
deficiency in a single reaction, but rather as a global adjustment of
Golgi biochemistry. We consider this an adaptive response to giantin
loss of function and it suggests a plasticity within the system that could
have relevance tomany processes, including cell differentiation, tissue
morphogenesis and responses to the extracellular environment. This
is supported by the fact that KO cells and zebrafish are both viable and
relatively unaffected by the transcriptional changes seen here. Indeed,
lectin binding is largely equivalent in WT and KO cells suggesting
that the new enzymatic equilibrium is broadly effective and the
fidelity of glycosylation is largely maintained.
Genetic adaptation is an increasingly reported response to
CRISPR/Cas9-generated mutations (Cerikan et al., 2016; Rossi
et al., 2015). Such changes mask the original gene function but
arguably better reflect disease states. Giantin depletion by siRNA
has been reported to cause the specific redistribution of
glucosaminyl (N-acetyl) transferase 3 (GCNT3) from the Golgi to
the ER (Petrosyan et al., 2012). Expression of this gene was
unaffected in our study but it is possible that perturbed transport of
other enzymes instigated the transcriptional changes seen here. We
found that giantin is not responsible for trafficking of GALNT3 to
Fig. 4. GALNT3 expression is lost in giantin-KO cells. (A) Western blot validating down-regulation of GALNT3 in KO cells (representative of n=5 biological
replicates). (B) Maximum projection images of mixed populations of WT and KO cells immunolabelled for giantin, GM130 and GALNT3. Arrows highlight giantin-
KO cells. (C) Representative projections of WT and KO cells expressing FLAG-tagged GALNT3 fixed and stained as indicated. Scale bars: 10 µm.
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Fig. 5. Giantin-KO zebrafish have reduced galnt3 expression and exhibit HFTC-like phenotypes. (A) Real-time qPCR pair-wise analysis of galnt3
expression at 60–63 dpf in two golgb1 mutant zebrafish lines normalised to gapdh mRNA levels as housekeeping gene. Bars show mean expression for each
mutant line (n=3 per genotype group) relative toWT siblings (WTexpression 1 AU depicted by dashed line). Each circle represents one individual (*P≤0.05, mean
with s.d.; unpaired t-test was used as datawere normally distributed). (B) Lateral views ofmicro-CT scans of 10-month-oldWTand golgb1X3078/X3078 homozygous
mutants, presented as isosurface renders. Boxed regions show enlarged regions in C. (C) Enlarged regions of the spine; white arrows demarcate intervertebral
discs (IVDs), which in WT are not mineralised but in the mutant, ectopic mineralisation is seen manifesting as vertebral fusions. (D) Ventral (with high-resolution
inset) and (E) lateral view micro-CT images showing craniofacial and spinal elements of a representative WT sibling (Q2948X line, n=3 females). (F–I) Three
golgb1Q2948X/Q2948X female individuals showing ectopic calcium deposits in soft tissues (F, ventral viewwith high-resolution inset; G, lateral view of individual 1; H,
ventral view of individual 2) and in spinal column (I, digital axial z-slices of individual 3). In D–I, red arrows indicate mandible joint and green arrows, ectopic
deposits. Line Q2948X were imaged at 8 months post fertilisation. Scale bars: 100 µm.
4139
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 4132-4143 doi:10.1242/jcs.212308
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
the Golgi, so transcriptional down-regulation of this enzyme at least
is not the result of an anterograde trafficking defect. In addition, we
do not detect any defects in cilia formation or function in giantin-
KO cells (Stevenson et al., 2017) or KO zebrafish (Bergen et al.,
2017) despite robust phenotypes following acute knockdown (using
RNAi; Asante et al., 2013; Bergen et al., 2017). Our previous work
showed that knockdown of giantin expression using RNAi resulted
in defects in cilia formation and function (Asante et al., 2013;
Bergen et al., 2017). To our surprise, giantin-KO RPE-1 cells show
no gross defects in ciliogenesis (Stevenson et al., 2017). Our RNA-
seq data and other experiments strongly suggest that RCAN2
compensates for loss of giantin in cilia length control (Stevenson
et al., 2017).
Glycosylation is a seemingly robust process, with multiple
compensatory mechanisms having been reported in response to
gene loss. For example, loss of MGAT in T cells leads to the
redistribution of sugar donors within Golgi cisternae to permit the
synthesis of structurally dissimilar but bioequivalent glycans
(Mkhikian et al., 2016). Interestingly, loss of MGAT expression
does not result in major changes in the expression of other
glycosyltransferases (Mkhikian et al., 2016). However, other work
has shown that loss of one N-acetylglucosaminyltransferase can
lead to compensatory upregulation of a functionally equivalent
isoform (Takamatsu et al., 2010). While these studies demonstrate
the capacity of glycosylation for self-correction with respect to a
single reaction, our data show for the first time the role of a non-
enzymatic Golgi protein in global control of glycosylation.
The GALNT family of enzymes comprises extensive overlapping
substrate specificities and so is a prime candidate for compensation
(Bennett et al., 2012; Schjoldager et al., 2015). Indeed, five GALNTs
are differentially expressed between WT and KO cells; GALNT1,
GALNT3, GALNT12 and GALNT16 were down-regulated whilst
GALNT5 was upregulated. Furthermore, staining with HPA lectin,
which binds to the Tn antigen generated by GALNTs, was equivalent
inWT and KO cell lines suggesting that the efficiency of this reaction
was broadly maintained following these changes. Increased
GALNT5 activity may therefore be sufficient to counter the loss of
the other four enzymes, or the remaining GALNTs act collectively to
ensure efficient O-glycosylation. The manifestation of HFTC-like
phenotypes in giantin-KO fish however is consistent with the idea that
loss of GALNT3 cannot be fully compensated for over time with
respect to specific substrates. This contrasts with other work showing
that deletion of either GALNT1 orGALNT2, or ectopic expression of
GALNT3, does not result in substantial changes in expression of the
other GALNTs (Schjoldager et al., 2015). Glycosylation deficiencies
for specific proteins have also been reported in prostate cancer cells
where giantin is non-functional (Petrosyan et al., 2014).
The observed changes in expression of genes encoding Golgi-
resident enzymes following loss of giantin expression suggests the
existence of a Golgi-based quality control pathway for glycosylation.
One interpretation of our data is that giantin itself is actively
monitoring glycan synthesis or cargo transit and adjusting gene
expression accordingly. Such organelle-based signalling circuits are
not without precedent; the nutrient sensor mTORC1 can interact with
and phosphorylate transcription factor EB (TFEB) on the surface of
lysosomes during starvation to promote its nuclear translocation
(Settembre et al., 2012). Giantin itself lacks enzymatic activity but it
could function as a signalling platform in this context. MAPK, PKD
and PKA signalling have all been shown to regulate Golgi activity
(Farhan and Rabouille, 2011) but whether any of these pathways
intersect with giantin and transcription remains to be determined. No
obvious trafficking defects were detected in the KO cells at steady
state, consistent with a function independent of vesicle tethering. This
agrees with a report showing that, unlike known tethers,
mitochondrial relocation of giantin does not result in vesicle
tethering to the mitochondrial membrane (Wong and Munro,
2014). Nonetheless the possibility remains that the control of intra-
Golgi traffic by giantin acts to ensure the accurate distribution of
enzymes across the stack and this intersects with a signalling loop that
directs expression of glycosyltransferases.
The lack of major structural changes in the Golgi apparatus in our
KO cells is consistent with mouse KO models (Lan et al., 2016) and
knockdown systems (Asante et al., 2013; Koreishi et al., 2013). It
has been reported that the introduction of giantin intoDrosophila S2
cells promotes clustering of Golgi stacks into pseudo-ribbons,
implying a role in lateral tethering (Koreishi et al., 2013). If this is
the case, then the lack of Golgi fragmentation in our KO models
indicates that other golgins might fulfil this function in vertebrate
systems. One notable phenotype that we observed was the presence
of circularised Golgi structures following nocodazole treatment in
giantin-KO cells. This is counter-intuitive to a role in lateral
tethering since removal of an inter-cisternal tether should reduce,
rather than encourage, interactions between cisternal rims.
Considering giantin has a predicted reach of 450 nm into the
cytosol it is possible that instead it blocks interaction between
similar membranes. During ribbon assembly, it would then need to
be excluded from the rims of the stacks that are coming together.
Alternatively, it may play a structural role in maintaining flat
cisternae through homo- or heterotypic interactions or regulate lipid
composition. We only see these circular structures following
disassembly, suggesting larger Golgi ribbon structures may be
under other physical constraints that maintain its linear
conformation. If giantin does have a role in maintaining cisternal
structure, changes in protein localisation or lipid packing in its
absence could play a role in controlling glycosyltransferase
expression. Relocation of GM130 to larger Golgi elements in
nocodazole-treated giantin-KO cells is consistent with its
accumulation on the ‘old Golgi’ and with at least a partial
compensation of function following loss of giantin.
Quality control mechanisms, such as may be active here, are well
documented in the ER but to our knowledge only one study has
looked at this specifically in the Golgi (Oku et al., 2011). This report
found ten Golgi-relevant genes were upregulated in response to
Golgi stress by virtue of a seven-nucleotide cis-acting element
within their promoters termed the Golgi apparatus stress response
element (GASE) (Oku et al., 2011). We failed to identify these
genes in our RNA-seq analysis, nor was there any enrichment for
promoters containing the GASE motif in our hits. It is therefore
unlikely that this pathway is active in our KO cells, but perhaps
similar mechanisms exist to detect changes in the proteoglycome
and adjust transcription accordingly.
Considerable variation exists between giantin-KO animal
models (Katayama et al., 2011; Lan et al., 2016). All, however,
exhibit defects that could be attributed to changes in glycosylation,
which, in turn, affects ECM deposition (Stanley, 2016; Tran and
Ten Hagen, 2013). Changes in this process due to altered
glycosyltransferase expression could thus underlie the broad
chondrogenesis and osteogenesis phenotypes seen in rodent KO
animals, whilst the diversity seen with regards to phenotypes likely
reflects model-specific modes of adaptation. The latter will be
determined by tissue-specific expression patterns, different
developmental pathways, or differing compensatory mechanisms
to produce bioequivalent glycans between species. Unlike our
zebrafish mutants, HFTC-like phenotypes have not been reported
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in rodent giantin-KO models. As HFTC is a late-onset disorder,
rodent models may not be able to develop HFTC-like
characteristics, since these animals die at birth, whilst adult KO
zebrafish are viable.
Overall, our work identifies a previously uncharacterisedmechanism
throughwhich the Golgi can regulate its own biochemistry to produce a
functional proteoglycome. Understanding the ability of cells to adapt
and modulate glycosylation pathways through long-term changes in
gene expression has implications for normal development and disease
pathogenesis in diverse contexts, including congenital disorders of
glycosylation (Jaeken, 2010), the onset and progression of cancer
(Pinho and Reis, 2015), and long-term health in terms of tissue
regeneration and repair.
MATERIALS AND METHODS
All reagents were purchased from Sigma-Aldrich unless stated otherwise.
Cell culture
Human telomerase-immortalised retinal pigment epithelial cells (hTERT-
RPE-1, ATCC) were grown in DMEM-F12 supplemented with 10% FCS
(Life Technologies, Paisley, UK). Cell lines were not authenticated after
purchase other than confirming absence of mycoplasma contamination.
Transfections were performed using Lipofectamine 2000 according to the
manufacturer’s instructions (Invitrogen, Carlsbad, CA). FLAG–GALNT3
was obtained from ViGene Biosciences (CH897457D) Str-Kdel/Man-
SBP-EGFP was a gift from Franck Perez (Institut Curie, Paris;
Boncompain et al., 2012). For drug treatments, cells were incubated
with 5 μM nocodazole (Santa Cruz, Heidelberg, Germany) or 5 μM
Brefeldin A diluted in growth medium at 37°C then washed three times
with growth medium for recovery.
Zebrafish husbandry and mutant alleles
London AB zebrafish were used and maintained in standard conditions
(Westerfield, 2000) and staged accordingly (Kimmel et al., 1995).
Ethical approval was obtained from the University of Bristol Ethical
Review Committee using the Home Office Project License number 30/
2863. The golgb1Q2948X and golgb1X3078 alleles are described in Bergen
et al. (2017).
Genome engineering
RPE-1 cells were transfected as above with 1 μg each of paired gRNAs
HSL0001186601 (ACCTGAGCACGGCCCACCAAGG) and HSR00011
86603 (GTCGTTGACTTGCTGCAACAGG) (obtained from Sigma)
targeting the GOLGB1 gene plus 0.1 μg pSpCas9n(BB)-2A-GFP (Addgene
plasmid, 48140 PX461; Ran et al., 2013). After 48 h, GFP-positive cells were
sorted into 96-well plates, seeding one cell per well to generate clones. To
identify mutations, genomic DNA was prepared using a Purelink genomic
DNA mini kit (Invitrogen) and the region targeted by the gRNAs amplified
by PCR [primers: forward, 5′-CTGGGTCTGGTTGTTGTTGGT-3′; reverse,
5′-GGTGTCATGTTGGTGCTCAG-3′; reaction mix: Taq DNA polymerase
with Thermopol buffer, 10 mM dNTP mix, 10 μM each primer and 2 μl
genomic DNA; reagents fromNEB (M0267L, N0447L)]. PCR products were
cloned into the pGEM T Easy vector according to the manufacturer’s
instructions (Promega) and sequenced using predesigned primers against the
T7 promoter (MWG Eurofins).
Antibodies, labelling and microscopy
Antibodies used were: mouse monoclonal anti-giantin (full length; Abcam,
ab37266; 1:500), rabbit polyclonal anti-giantin (N-terminus; Covance,
PRB-114C), rabbit polyclonal anti-giantin (C-term; gift from Martin Lowe,
University of Manchester, Manchester, UK; 1:500), mouse anti-GM130 and
mouse GMAP210 (BD Biosciences, BD 610823 and BD 611712; 1:500),
sheep anti-TGN46 (Bio-Rad, AHP500; 1:500), sheep anti-GRASP65 (gift
from Jon Lane, University of Bristol, Bristol, UK; 1:500), rabbit anti-Sec23a
(labmade, polyclonal; 1:100), mouse anti-ERGIC53 (monoclonal clone G1/
93, Alexis Biochemicals, ALX-804-602-C100; 1:200), rabbit anti-TFG
(Novus Biologicals, IMG5901A; 1:500), Sec16A (KIAA0310, Bethyl Labs,
Montgomery, TX, A300-648A; 1:500), ER stress antibody sampler kit (Cell
Signaling, 9956; 1:200–1:1000), mouse anti-tubulin, rabbit anti-GALNT3
and rabbit polyclonal anti-FLAG (Sigma, T5168, HPA007613 and F7425;
1:2000, 1:1000, and 1:1000 respectively), CASP (gift from Sean Munro,
LMB Cambridge, UK; 1:1000), mouse anti-GAPDH (Abcam, ab9484;
1:500) and sheep anti-GALNT3 (R&D systems, AF7174; 1:200). Lectins
used were: HPA biotinylated lectin (Fisher Scientific, L11271), Biotinylated
lectin kit I (Vector laboratories, BK-1000). HABP (Merck, 385911).
For antibody labelling, cells were grown on autoclaved coverslips
(Menzel #1.5, Fisher Scientific), rinsed with PBS and fixed inmethanol for
4 min at −20°C. Cells were then blocked in 3% BSA-PBS for 30 min and
incubated with primary then secondary antibody for 1 h each, washing in
between. Nuclei were stained with DAPI (4,6-diamidino-2-phenylindole;
Life Technologies, D1306) for 3 min and coverslips mounted in Mowiol
(MSD) or Prolong Diamond antifade (Thermo Fisher). For lectin labelling,
cells were washed in PBS and fixed in 3% PFA-PBS for 10 min at room
temperature (for lectins) or 10 min on ice plus 10 min at room temperature
(for HABP). Cells were permeabilised in 1% (lectins) or 0.1% (HABP)
Triton X-100 in PBS and blocked as above. Biotinylated lectins were
diluted to 4 μg/ml in block and incubated with cells for 40 min whilst HAPB
was diluted to 5 μg/ml and incubated overnight at 4°C. Cells were washed
with PBS, incubated with anti-giantin antibody for 15 min, washed and
labelled with streptavidin-A568 and anti-rabbit A488 (Fisher Scientific,
S11226). Cells were then stained with DAPI and mounted as above.
Fixed cells were imaged using an Olympus IX70 microscope with
60×1.42 NA oil-immersion lens, Exfo 120 metal halide illumination with
excitation, dichroic and emission filters (Semrock, Rochester, NY), and a
Photometrics Coolsnap HQ2 CCD, controlled by Volocity 5.4.1 (Perkin
Elmer). Chromatic shifts in images were registration corrected using
TetraSpek fluorescent beads (Thermo Fisher). Images were acquired as
0.2 µm z-stacks.
For RUSH assays, cells were seeded onto 35-mm glass-bottomed dishes
(MatTek, Ashland, MA) or coverslips and transfected 24 h prior to assay; at
T0 cells were treated with 40 µM biotin then imaged every 15 s as a single
plane for up to 1 h or fixed at specific time points and stained as above. Live
wide-field microscopy proceeded using an Olympus IX81 microscope with
60×1.42 numerical aperture oil-immersion lens, Sutter DG4 illumination
with excitation filters, and multi-pass dichroic and multi-pass emission
filters (Semrock). Images were collected using an Orca Flash 2.8 sCMOS
controlled using Volocity 5.4.2 (PerkinElmer). Cells were kept at 37°C for
the duration of the imaging.
Quantification of Golgi structure from wide-field images was performed
using ImageJ software. Maximum projection images (GRASP65 channel)
were generated from 0.2 µm z-stacks and thresholded before applying the
‘analyse particles’ feature, excluding objects <0.5 μm2 or on the edge of the
field of view. Golgi cisternal length and curvature measurements taken from
micrographs were again made with ImageJ using the segmented line and
angle tools. Cisternae number and RUSH experiments were quantified
manually and blind.
Electron microscopy
Cells were fixed in 2.5% glutaraldehyde, washed for 5 min in 0.1 M
cacodylate buffer then post-fixed in 1%OsO4 in 0.1 M cacodylate buffer for
30 min. Cells were washed three times with water and stained with 3%
uranyl acetate for 20 min. After another rinse with water, cells were
dehydrated by sequential 10 min incubations with 70, 80, 90, 96, 100 and
100% ethanol before embedding in Epon at 70°C for 48 h. Thin 70 nm serial
sections were cut and stained with 3% uranyl acetate then lead citrate,
washing three times with water after each. Once dried, sections were imaged
using an FEI Tecnai12 microscope.
Immunoblotting
Cells were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl,
2% Triton X-100, 1% deoxycholate, 0.1% SDS, 1 mM EDTA) and samples
separated by SDS-PAGE followed by transfer to nitrocellulose membranes.
Membranes were blocked in 5% milk in TBST (TBS with 0.05% Tween) or
3% BSA-TBST for antibody and lectin probes, respectively. Primary
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antibodies or lectins diluted in block were incubated with membrane
overnight and detected using HRP-conjugated secondary antibodies or
streptavidin, respectively (Jackson ImmunoResearch) and enhanced
chemiluminescence (GE Healthcare).
Quantitative PCR
Total RNA was isolated from ventral bone and cartilage of juvenile
golgb1Q2948X and golgb1X3078 genotyped fish (60 and 63 dpf, respectively,
n=3 per genotype) using RNeasy mini kit (74104, Qiagen). Subsequently, a
reverse transcriptase reaction was performed by using Superscript IV
(18091050, Thermo Fisher). Zebrafish galnt3 (XM_009300463.2) coding
sequence was confirmed by multi-species nucleotide BLAST (NCBI)
leading to galnt3 forward, 5′-TCCTTCAGAGTGTGGCAGTG and reverse,
5′-TGATGGTGTTGTGGCCTTTA primers. gapdhwas used as a reference
gene (forward, 5′-TGTTCCAGTACGACTCCACC and reverse, 3′-
GCCATACCAGTAAGCTTGCC). Quantitative real-time PCR (qPCR)
reactions (quadruplicates per individual) using DyNAmo HS SYBR green
(F410L, Thermo Fisher) with PCR cycles (40 times) of 95°C for 25 s,
57.5°C for 30 s and 70°C for 45 s, followed by a standard melt curve were
applied (QuantStudio3, Applied Biosystems).
RNA-seq
Triplicate samples of mRNA from giantin-KO cells and WT RPE-1 cells
were analysed by RNA-seq by the Earlham Institute (formerly The Genome
Analysis Centre). The libraries were constructed by The Earlham Institute
on a PerkinElmer Sciclone using the TruSeq RNA protocol v2 (Illumina
15026495 Rev.F). The library preparation involved initial quality control of
the RNA using a Tecan plate reader with the Quant-iT RNA Assay Kit (Life
technologies/Invitrogen, Q-33140) and the Quant-iT DNA Assay Kit, high
sensitivity (Life technologies/Invitrogen, Q-33120). Finally, the quality of
the RNAwas established using the PerkinElmer GX with a high-sensitivity
chip and High Sensitivity DNA reagents (PerkinElmer, 5067-4626). RNA
quality scores were 8.7 and 9.8 for two of the samples and 10.0 (for the
remaining four samples). 1 μg of RNAwas purified to extract mRNAwith a
poly-A pull down using biotin beads, fragmented and the first-strand cDNA
was synthesised. This process reverse transcribes the cleaved RNA
fragments primed with random hexamers into first-strand cDNA using
reverse transcriptase and random primers. The ends of the samples were
repaired using the 3′ to 5′ exonuclease activity to remove the 3′ overhangs
and the polymerase activity to fill in the 5′ overhangs creating blunt ends. A
single ‘A’ nucleotide was added to the 3′ ends of the blunt fragments to
prevent them from ligating to one another during the adaptor ligation
reaction. A corresponding single ‘T’ nucleotide on the 3′ end of the adaptor
provided a complementary overhang for ligating the adaptor to the fragment.
This strategy ensured a low rate of chimera formation. The ligation of a
number indexing adaptors to the ends of the DNA fragments prepared them
for hybridisation onto a flow cell. The ligated products were subjected to a
bead-based size selection using XP beads (Beckman Coulter, A63880) to
remove un-ligated adaptors, as well as any adaptors that may have ligated to
one another. Prior to hybridisation to the flow cell, the samples were
amplified by PCR to selectively enrich those DNA fragments that have
adaptor molecules on both ends and to amplify the amount of DNA in the
library. The PCRwas performed with a PCR primer cocktail that annealed to
the ends of the adaptor. The insert size of the libraries was verified by
running an aliquot of the DNA library on a PerkinElmer GX using the High
Sensitivity DNA chip and reagents (PerkinElmer CLS760672) and the
concentration was determined by using a Tecan plate reader. The resulting
libraries were then equimolar pooled and Q-PCRwas performed on the pool
prior to clustering.
These six total RNA samples were sequenced over two lanes and aligned
against the human genome reference build 38 followed by differential
expression analysis between the WT and KO samples. QC was done
using FastQC (v.0.11.2). An in-house contamination-screening pipeline
(Kontaminant) was used to check for any obvious contamination in the raw
reads. Since the data quality was good, therewas no trimming done on the raw
reads. Alignment of RNA-seq reads to the human genome referencewas done
using TopHat (v.2.1.0) with ‘min-anchor-length’ 12 and ‘max-multi hits’ 20.
The log2 of the fold-change was used in further analysis.
Micro-computed tomography scanning (µCT)
Female fish (n=3) carrying golgb1WT/WT and mutant golgb1Q2948X/Q2948X
alleles were preserved in absolute ethanol at 8 mpf. Prior to scanning, the
samples were packed in a polystyrene tube and scanned with a Bruker
SkyScan 1272 (Kontich, Belgium) at a 21.8 or 4 μm resolution. The X-ray
current was set at 200 μA with a voltage of 50 kV.
Eight zebrafish (four wild-type and four mutant golgb1X3078/ X3078 fish)
were scanned together using a Nikon X-TEK 225 HT computed
tomography (CT) scanner at a resolution of 21 μm. Fish were arranged
in a circle with seven on the outside surrounding the eighth fish. The
first specimen was labelled so it was identifiable in the CT scans using a
radiopaque sticker, and the remaining fish were numbered clockwise.
3D tomography images and movies for the golgb1Q2948X allele were
generated using CTvox software (v.3.0.0). For the golgb1X3078 allele and
siblings the fish were segmented using Avizo (v.9.3, Visualization Sciences
Group), by thresholding greyscale values and labelling specific regions,
bones and individual fish in materials for 3D visualisation. BMD was
calculated relative to phantoms of known hydroxyl appetite density 0.25 and
0.75 g/cm3 in three regions: for the skull, the lower jaw and vertebrae from
multiple slices: 25 anteroposterior slices for the sagittal, the anterior-most 15
anteroposterior slices for the lower jaw, and the posterior half of the last
vertebra before the end of the ribs. Using the Material Statistics module of
Avizo, the mean greyscale value was calculated for each of these regions for
each fish. BMD in each region was then calculated by multiplying the
greyscale mean value by the maximum of 2.5 arbitrary units divided by the
actual greyscale maximum of 65535. Finally, measurements of maximum
lower jaw width and length were measured using the 3D CT reconstruction
for both alleles.
Quantification and statistical analysis
Statistical analyses were performed using GraphPad Prism 7.00. The tests
used, n numbers and sample sizes are indicated in the figure legends,
P-values are shown on the figures. All tests met standard assumptions and
the variation between each group is shown. Sample sizes were chosen based
on previous, similar experimental outcomes and based on standard
assumptions. No samples were excluded. Randomisation and blinding
were not used except where the genotype of zebrafish was determined after
experimentation.
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